On August 18, 2026, Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA) announced that its wholly owned subsidiary, Rocket Doctor Inc.(“Rocket Doctor”) has entered into a strategic provider network agreement with a leading national technology-enabled network solutions partner to expand access to physician-led care across multiple channels in California. This agreement provides Rocket Doctor with participation advantage by focusing on networks including primary, complementary, workers' compensation, auto medical, and Medicare, unlike traditional payer agreements focused on a single line of business.
Through this partnership, Rocket Doctor has created the opportunity to work with upstream insurers, employer health plans, and other health care organizations. This national network serves more than 700 health plans, over 100,000 employers, roughly 60 million consumers, and includes 1.4 million contracted providers. This agreement became effective on July 1, 2026, with an initial one-year term with automatic annual renewals. The company considers this opportunity to be a further expansion of its U.S. strategy.
Expanding its footprint in California is a key operational priority for Rocket Doctor. Integrating California-compliant telehealth standards into the agreement ensures full alignment for covered service reimbursement, providing a strong foundation to capture further market demand. It will also establish a new contracted entry point into the California workers' compensation market.
"This agreement is particularly exciting because of the breadth of access it creates through a single relationship," said Dr. William Cherniak, Co-Founder and CEO of Rocket Doctor Inc. "As we continue to scale in California, expanding beyond traditional health insurance into areas such as workers' compensation and auto medical creates new opportunities for physicians to reach patients who need timely care. It is another important step toward building a diversified and sustainable reimbursement infrastructure around physician-led virtual care."
As a company, Rocket Doctor AI is focused on creating and providing physician-built, AI-powered solutions designed to make high-quality healthcare accessible remotely.
Telehealth Market Expanding Rapidly
The global telehealth market was valued at US$186.41 billion in 2025 and is projected to grow to US$219.31 billion in 2026, reaching US$1,272.81 billion by 2034 at a CAGR of 24.60%. North America was the largest regional market for telehealth in 2025, accounting for roughly 45% of global revenue.
In its 2026 Telehealth Market Outlook report, healthcare recruitment firm Storm3 pointed to reimbursement modernization as a defining trend for the sector this year, noting that new CMS billing codes and proposed SaaS-based pricing models reflect a shift toward digital platforms becoming "central to reimbursable care". The report also flagged regulatory uncertainty as an ongoing pressure point, citing an approaching "policy cliff" that has prompted calls from the American Telemedicine Association for permanent federal telehealth policy.
Workers' compensation is emerging as a distinct growth channel in virtual care. According to Risk Placement Services' 2026 US Workers' Compensation Market Outlook, rising medical costs and litigation trends are reshaping the market, with California's claims environment cited as a particular driver of nationwide change. Separately, an industry analysis of workers' comp technology trends noted that Medicare telehealth flexibilities were extended through December 31, 2027, giving carriers and self-insured groups more runway to build out telehealth infrastructure with "greater regulatory confidence".
That extended runway comes as the broader U.S. workers' compensation personal injury and PPO market is expected to grow at a 5.4% CAGR from 2026 to 2033, due to telehealth and digital care coordination platforms as key levers for improving claims efficiency and medical cost containment.
Analysts See Momentum, Reiterate Bullish Ratings
1On March 17, 2026, technical analyst Stewart Thomson said that Rocket Doctor AI is "gaining momentum" as a digital health platform that helps make healthcare more accessible, especially to those in rural communities. "Virtual care offers convenience, flexibility, and ongoing access to a healthcare team, making it an excellent alternative to traditional clinic visits. However, not all "virtual care" platforms and services are alike," Thomson argued, noting that Rocket Doctor AI was built by doctors, so ". . . doctors who use it get exactly what they need."
Thomson gave the company a "Strong Speculative Buy" rating, with a short-term technical price target of CA$0.80, a medium-term target of CA$1.00, and a long-term target of CA$1.60.
Most recently, Sid Rajeev of Fundamental Research Corp. reiterated a "Buy" rating and price target of CA$1.55 on June 11, 2026, stating: "While Q1 results were impacted by higher costs and lower-than-expected patient volumes, we believe underlying growth trends remain intact. Supported by U.S. expansion, rising patient volumes, and sufficient liquidity, we expect meaningful operational and financial improvement over the coming quarters."
Catalysts Include State Expansion, Rising Patient Volumes, and AI Tool
According to its August investor overview, Rocket Doctor AI's near-term catalysts center on expanding its U.S. payer and physician network. The company’s August investor presentation identifies Florida and Texas, among other states, as part of its expansion pipeline, while its strategy includes extending existing payer relationships. The company reported it had achieved its initial U.S. growth from 22 clinically active U.S. physicians, several of whom were only onboarded mid-quarter following credentialing completion, and 33 physicians in credentialing, with imminent additional physician capacity expected to support higher patient volumes.
Another potential catalyst is growth in reimbursed patient volume. Rocket Doctor reported U.S. completed patient visits increasing from 86 in December 2025 to 1,144 in April 2026, while U.S. clinical hours rose from 75 to 624 over the same period. The company says each new payer relationship can potentially provide access to 1 million to 2 million or more covered lives, creating a potential path to additional patient volume and revenue as payer relationships expand.
The company is also developing AI-enabled tools for patient intake, clinical visits, documentation, and follow-up, with AI agents and clinical intelligence positioned as part of its broader platform. Rocket Doctor says these tools are designed to support providers rather than replace them. Further development and deployment of these AI capabilities, alongside expansion of its virtual-care network, could provide additional catalysts as the company works to scale its U.S. operations.
Ownership & Share Information2
Rocket Doctor AI Inc. has a market cap of CA$60.62 million, with 101.04 million shares outstanding. The company's 52-week range is CA$0.50-CA$0.98. Management & Insiders own 4.24% of shares, while the remaining 95.76% of shares are Retail.
Streetwise Ownership Overview*
Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA)
| Date | Old Symbol | Old Shares | New Symbol | New Shares |
|---|---|---|---|---|
| 08/21/25 | TRUE:OTC | 1 | AIDR:OTC | 1 |
| 11/09/23 | TREID:CSE | 10 | TREIF:CSE | 1 |
| 07/14/23 | TRUE:OTC | 10 | TRUE:OTC | 1 |
| 07/14/23 | TREIF:CSE | 1 | TREID:CSE | 1 |
Frequently Asked Questions
Q: What is telehealth?
A: Telehealth uses telecommunications technology to provide healthcare services remotely, including virtual doctor visits, consultations, follow-up care, and other clinical services.
Q: How does telehealth work?
A: Telehealth allows patients and healthcare providers to connect remotely through secure digital platforms. Depending on the service, patients may receive consultations, diagnoses, treatment recommendations, or follow-up care without visiting a clinic in person.
Q: What are the benefits of telehealth?
A: Telehealth can improve access to healthcare by allowing patients to connect with providers remotely. It may reduce travel requirements, improve convenience, and help expand access to care in rural or underserved areas.
Q: How does telehealth reimbursement work?
A: Telehealth reimbursement allows healthcare providers to receive payment from insurers, employers, or other healthcare organizations for eligible virtual services. Coverage and reimbursement requirements can vary by payer, state, and type of healthcare service.
Q: What is a telehealth provider network?
A: A telehealth provider network connects physicians and other healthcare providers with insurers, employers, health plans, and patients. These networks can help providers gain access to covered patients and establish reimbursement pathways for eligible virtual healthcare services.
Q: What is the future of telehealth?
A: Telehealth is increasingly being incorporated into healthcare delivery alongside traditional in-person care. Continued development of reimbursement models, virtual-care infrastructure, and AI-enabled healthcare tools could support further adoption of telehealth and digital health services.
| Want to be the first to know about interesting Life Sciences Tools & Diagnostics and Artificial Intelligence investment ideas? Sign up to receive the FREE Streetwise Reports' newsletter. | Subscribe |
Important Disclosures:
- Rocket Doctor AI Inc. is a billboard sponsor of Streetwise Reports. The company pays a monthly sponsorship fee of US$3,000–US$6,000 for banner advertising and an enhanced company profile page. Streetwise Reports’ editorial content is fully independent and is not influenced by sponsorship.
- As of the date of this article, officers, contractors, shareholders, and/or employees of Streetwise Reports LLC (including members of their household) own securities of Rocket Doctor AI Inc.
- Cori Fisher wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
- This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.
For additional disclosures, please click here.
1. Disclosure for the quote from the Stewart Thomson article published on March 17, 2026
1. For the quoted article (published on March 17, 2026), Rocket Doctor AI Inc. has paid Street Smart, an affiliate of Streetwise Reports, US$2,500.
2. Author Certification and Compensation: Stewart Thomson was retained and compensated as an independent contractor by Street Smart for writing this article. Mr. Thomson is a retired Canadian financial advisor who has passed the Canadian Securities Course as well as additional technical analysis courses that were mandated by his former employer and approved by Ontario regulatory bodies. For the past 15 years, he has been editing and writing numerous financial newsletters that have a strong focus on charts. The recommendations and opinions expressed in this content reflect the personal, independent, and objective views of the author regarding any and all of the companies discussed. No part of the compensation received by the author was, is, or will be directly or indirectly tied to the specific recommendations or views expressed.
2. Ownership and Share Structure Information
The information listed above was updated on the date this article was published and was compiled from information from the company and various other data providers.




















































